CHINA TRADITIONAL CHINESE MEDICINE HOLDINGS CO. LIMITED

China Traditional Chinese Medicine Holdings Co. Limited

570 HK0000056256

Pharmaceuticals

Market Closed - Hong Kong S.E. Other stock markets 04:08:08 2024-06-04 am EDT			5-day change	1st Jan Change
4.28 ^HKD	+1.18%		+1.18%	+8.91%

May. 14	China Traditional Chinese Medicine, Sinopharm Update on Privatization Process Status	MT
Mar. 22	China Traditional Chinese Medicine Posts 94% Profit Growth in 2023	MT

China Traditional Chinese Medicine Holdings Co. Limited Does Not Recommend the Payment of an Interim Dividend for the Six Months Ended 30 June 2022

August 26, 2022 at 10:19 am EDT

China Traditional Chinese Medicine Holdings Co. Limited announced that the directors of the Company do not recommend the payment of an interim dividend for the six months ended 30 June 2022 (six months ended 30 June 2021: 6.66 HK cents per share).

Latest news about China Traditional Chinese Medicine Holdings Co. Limited

China Traditional Chinese Medicine, Sinopharm Update on Privatization Process Status	May. 14	MT
China Traditional Chinese Medicine Posts 94% Profit Growth in 2023	Mar. 22	MT
China Traditional Chinese Medicine Holdings Co. Limited Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 21	CI
China Traditional Chinese Medicine Holdings Co. Limited Announces Re-Designation of CHENG Xueren from Managing Director to Non-Executive Director	Mar. 21	CI
China Traditional Chinese Medicine Holdings Co. Limited Announces Board Changes	Mar. 21	CI
China Traditional Chinese Medicine's Stock Bolts on Privatization Offer	Feb. 22	MT
China stocks extend gains led by coal, AI; HK shares up	Feb. 22	RE
Hong Kong Stocks Hover Near Two-Month Highs Amid Mixed Corporate Earnings	Feb. 22	MT
China stocks jump with AI shares leading on Nvidia forecast; HK shares flat	Feb. 21	RE
Sinopharm offers to take China-TCM private in nearly $3 bln deal	Feb. 21	RE
Sinopharm Common Wealth Company Limited entered into a scheme of arrangement to acquire 67.54% stake in China Traditional Chinese Medicine Holdings Co. Limited for HKD 15.6 billion.	Feb. 20	CI
China Traditional Chinese Medicine Holdings Forecasts Up to 95% Surge in 2023 Profit; Shares Rise 4%	Jan. 29	MT
China Traditional Chinese Medicine Holdings Co. Limited Provides Preliminary Unaudited Consolidated Earnings Guidance for the Year Ended 31 December 2023	Jan. 28	CI
China Traditional Chinese Medicine Holdings Co. Limited Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-29	CI
China Traditional Chinese Medicine Holdings Co. Limited Announces Resignation of Kui Kaipin as Non-Executive Director, with Effect from August 29, 2023	23-08-29	CI
China Traditional Chinese Medicine's Profit to Climb Up to 55% in H1; Shares Up 3%	23-07-28	MT
China Traditional Chinese Medicine Holdings Co. Limited Provides Consolidated Earnings Guidance for the Six Months Ended June 30, 2023	23-07-27	CI
China Traditional Chinese Medicine Raises Issues 800 Million Yuan of 270-Day Bonds	23-07-20	MT
China Traditional Chinese Medicine Holdings Co. Limited Approves Final Dividend for the Year Ended 31 December 2022	23-05-30	CI
China Traditional Chinese Medicine Raises 2.2 Billion Yuan from Issuing Two Series of Bonds	23-05-24	MT
China Traditional Chinese Medicine Holdings Co. Limited Proposes Final Dividend for the Year Ended 31 December 2022	23-05-05	CI
China Traditional Chinese Medicine Holdings Co. Limited Proposes Final Dividend for the Year Ended 31 December 2022, Payable on 20 June 2023	23-03-24	CI
China Traditional Chinese Medicine Holdings Co. Limited Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-24	CI
China Traditional Chinese Medicine Forecasts Up to 70% Decline in FY22 Profit	23-01-16	MT
China Traditional Chinese Medicine Holdings Co. Limited Provides Preliminary Unaudited Consolidated Group Earnings Guidance for the Year Ended 31 December 2022	23-01-16	CI

Chart China Traditional Chinese Medicine Holdings Co. Limited

Duration

Period

Chart China Traditional Chinese Medicine Holdings Co. Limited

More charts

Company Profile

China Traditional Chinese Medicine Holdings Co. Limited is principally engaged in the manufacture and sales of traditional Chinese medicine (TCM). The Company operates through 12 subsidiaries, including Sinopharm Group Dezhong (Foshan) Pharmaceutical Co., Ltd., Sinopharm Group Feng Liao Xing (Foshan) Pharmaceutical Co., Ltd., Sinopharm Group Guangdong Medi-World Pharmaceutical Co., Ltd., Sinopharm Group Luya (Shandong) Pharmaceutical Co., Ltd., Sinopharm Group Feng Liao Xing (Foshan) Medicinal Material & Slices Co., Ltd., Foshan Winteam Pharmaceutical Sales Company Limited, Sinopharm Group Tongjitang (Guizhou) Pharmaceutical Co., Ltd., Sinopharm Group Jingfang (Anhui) Pharmaceutical Co., Ltd., Sinopharm Group Longlife (Guizhou) Pharmaceutical Co., Ltd., Qinghai Pulante Pharmaceutical Co., Ltd., Guizhou Zhongtai Biological Technology Company Limited and its subsidiaries and Jiangyin Tianjiang Pharmaceutical Co., Ltd. and its subsidiaries.

Sector

Pharmaceuticals

Calendar

2024-08-22 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for China Traditional Chinese Medicine Holdings Co. Limited

Trading Rating

Investor Rating

ESG Refinitiv

C+

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

3.966 CNY

Average target price

4.574 CNY

Spread / Average Target

+15.31%

Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

	1st Jan change	Capi.
CHINA TRADITIONAL CHINESE MEDICINE HOLDINGS CO. LIMITED	+8.91%	2.72B
ELI LILLY AND COMPANY	+42.35%	748B
NOVO NORDISK A/S	+34.11%	598B
JOHNSON & JOHNSON	-5.99%	356B
MERCK & CO., INC.	+18.04%	325B
ABBVIE INC.	+4.49%	283B
ASTRAZENECA PLC	+17.02%	245B
NOVARTIS AG	+9.26%	211B
ROCHE HOLDING AG	-4.21%	209B
PFIZER, INC.	+2.85%	166B

Other Pharmaceuticals